Clinical Trial Update: Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing biphasic insulin aspart 50 with biphasic human insulin 50 as add-ons to metformin in Chinese adults with Type 2 diabetes; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic human insulin 50 (insulin human regular and insulin human isophane suspension)
• Biphasic insulin aspart 50 (insulin aspart, biphasic 50/50)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2015-07-09